E. Tanis

Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial

Bernard Nordlinger, Halfdan Sørbye, Bengt Glimelius et al. · The Lancet Oncology · 2013 · 1.3K citations

Perioperative Folfox4 Chemotherapy, Surgical Oncology, Hepatology +10

Local recurrence rates after radiofrequency ablation or resection of colorectal liver metastases. Analysis of the European Organisation for Research and Treatment of Cancer #40004 and #40983

E. Tanis, Bernard Nordlinger, Murielle Mauer et al. · European Journal of Cancer · 2014 · 218 citations

European Organisation, Surgical Oncology, Hepatology +14

Hartmann's procedure versus sigmoidectomy with primary anastomosis for perforated diverticulitis with purulent or faecal peritonitis (LADIES): a multicentre, parallel-group, randomised, open-label, superiority trial

Daniël P. V. Lambrichts, Sandra Vennix, Gijsbert D. Musters et al. · ˜The œLancet. Gastroenterology & hepatology · 2019 · 188 citations · Full text

Primary Anastomosis, Superiority Trial, Gastroenterology +6

Prognostic impact of immune response in resectable colorectal liver metastases treated by surgery alone or surgery with perioperative FOLFOX in the randomised EORTC study 40983

E. Tanis, Catherine Julié, Jean‐François Emile et al. · European Journal of Cancer · 2015 · 76 citations

Surgical Oncology, Prognostic Impact, Hepatology +9

Real-time in vivo assessment of radiofrequency ablation of human colorectal liver metastases using diffuse reflectance spectroscopy

E. Tanis, Jarich W. Spliethoff, Daniel J. Evers et al. · European Journal of Surgical Oncology · 2015 · 48 citations · Full text

Engineering, Medical Imaging, Radiofrequency Ablation +11